Loading stock data...

Indegene Limited

NSE: INDGN BSE: INDGN

NSE
546.45 -2.40 (-0.44%)

Prev Close

548.85

Open Price

550

Volume

394,741

Today Low / High

543.6 / 555.95

52 WK Low / High

499 / 736.3

Range

519 - 574

BSE
546.55 -2.30 (-0.42%)

Prev Close

548.85

Open Price

543.6

Volume

15,571

Today Low / High

543.6 / 555.45

52 WK Low / High

485.15 / 736.6

Range

519 - 574

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 546.45 (target range: 519 - 574), reflecting a change of -2.4 (-0.43728%). On the BSE, it is listed at 546.55 (target range: 519 - 574), showing a change of -2.3 (-0.41906%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

25 Jul 556.80 -0.17%
24 Jul 561.00 -0.78%
23 Jul 553.40 1.00%
22 Jul 563.00 -2.24%
21 Jul 576.90 -2.68%
18 Jul 578.40 -0.52%
17 Jul 581.40 -0.88%
16 Jul 579.00 0.39%
15 Jul 565.00 2.13%
14 Jul 566.50 -0.49%
11 Jul 569.55 -0.98%
10 Jul 577.95 -1.25%
09 Jul 562.95 1.99%
08 Jul 570.00 -1.39%
07 Jul 568.10 0.01%
04 Jul 568.25 -0.13%
03 Jul 570.00 -0.66%
02 Jul 573.05 -0.53%

Indegene Limited Graph

Indegene Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Indegene Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 546.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 546.55 552.02 496.81 - 607.22
557.48 445.98 - 668.98
562.95 394.06 - 731.83
Bearish Scenario 546.55 541.08 486.98 - 595.19
535.62 428.50 - 642.74
530.15 371.11 - 689.20

Overview of Indegene Limited

ISIN

INE065X01017

Industry

Medical - Healthcare Information Services

Vol.Avg

1,183,174

Market Cap

133,442,720,511

Last Dividend

2

Official Website

Visit Website

IPO Date

2024-05-13

DCF Diff

23.68

DCF

529

Financial Ratios Every Investor Needs

Stock Dividend of INDGN

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-06-13 June 13, 25 2 2 2025-06-13 2025-07-26

Stock Rating Details for INDGN

Metric Value Recommendation
Overall Rating A- Buy
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 3 Neutral
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2,839.30 Cr 2,067.20 Cr 2,839.30 Cr 1.0000 0.00 Cr 0.00 Cr 1,024.10 Cr 406.70 Cr 17.15 534.30 Cr 0.1432
2024-03-31 2,589.60 Cr 58.80 Cr 2,530.80 Cr 0.9773 0.00 Cr 0.00 Cr 874.80 Cr 336.70 Cr 14.09 584.10 Cr 0.1300
2023-03-31 2,306.13 Cr 41.24 Cr 2,264.89 Cr 0.9821 0.00 Cr 85.81 Cr 379.47 Cr 266.10 Cr 11.12 454.19 Cr 0.1154
2022-03-31 1,664.61 Cr 32.46 Cr 1,632.15 Cr 0.9805 0.00 Cr 54.46 Cr 273.56 Cr 164.76 Cr 6.89 265.91 Cr 0.0990
2021-03-31 966.27 Cr 15.65 Cr 950.63 Cr 0.9838 8.83 Cr 37.25 Cr 225.74 Cr 149.41 Cr 6.24 260.34 Cr 0.1546

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 374.60 Cr 3,325.90 Cr 710.30 Cr 2,615.6000 Cr 101.60 Cr -273.00 Cr 0.00 Cr 138.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 564.5000 Cr
2024-03-31 188.60 Cr 2,545.60 Cr 1,116.50 Cr 1,429.1000 Cr 489.60 Cr 301.00 Cr 0.00 Cr 114.40 Cr 35.20 Cr 0.00 Cr 19.80 Cr 610.9000 Cr
2023-03-31 73.59 Cr 2,203.87 Cr 1,140.14 Cr 1,063.7220 Cr 502.58 Cr 429.00 Cr -614.04 Cr 151.78 Cr 390.35 Cr 0.00 Cr 0.00 Cr 489.1460 Cr
2022-03-31 506.28 Cr 1,353.47 Cr 589.57 Cr 763.9000 Cr 65.75 Cr -440.53 Cr -119.86 Cr 79.88 Cr 343.16 Cr 0.00 Cr 0.00 Cr 440.4390 Cr
2021-03-31 133.36 Cr 596.04 Cr 262.96 Cr 324.5130 Cr 51.39 Cr -81.97 Cr 0.00 Cr 46.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 199.4290 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 441.9000 Cr -682.7000 Cr 287.5000 Cr 411.9000 Cr 52.4000 Cr 241.0000 Cr -30.0000 Cr 406.7000 Cr -434.9000 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 507.7000 Cr -327.2000 Cr -66.2000 Cr 497.0000 Cr 115.0000 Cr 188.6000 Cr -10.7000 Cr 336.7000 Cr -34.6000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 130.2180 Cr -893.3480 Cr 333.0890 Cr 111.3840 Cr -432.6940 Cr 73.5850 Cr -18.8340 Cr 363.0470 Cr 376.0980 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 297.0420 Cr -160.2070 Cr 233.4770 Cr 272.3330 Cr 372.9170 Cr 506.2790 Cr -24.7090 Cr 226.4960 Cr -23.2250 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 172.0330 Cr -24.2490 Cr -131.5060 Cr 151.4170 Cr -40.4990 Cr 133.3620 Cr -20.6160 Cr 195.8470 Cr -126.4410 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 755.60 Cr 0.00 Cr 755.60 Cr 1.0000 270.50 Cr 117.60 Cr 4.91 146.85 Cr 0.1556
2024-12-31 720.40 Cr 0.00 Cr 720.40 Cr 1.0000 111.80 Cr 109.70 Cr 4.59 169.50 Cr 0.1523
2024-09-30 686.80 Cr 580.10 Cr 106.70 Cr 0.1554 106.70 Cr 91.70 Cr 3.84 147.50 Cr 0.1335
2024-06-30 676.50 Cr 567.70 Cr 108.80 Cr 0.1608 108.80 Cr 87.70 Cr 3.79 151.40 Cr 0.1296
2024-03-31 673.00 Cr 0.00 Cr 673.00 Cr 1.0000 120.20 Cr 94.80 Cr 4.24 158.21 Cr 0.1409

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 374.60 Cr 1,289.70 Cr 1,664.30 Cr 751.40 Cr 0.00 Cr 2,530.00 Cr 138.50 Cr 3,325.90 Cr 710.30 Cr
2024-12-31 0.00 Cr 0.00 Cr 1,466.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -2,360.00 Cr
2024-09-30 311.90 Cr 1,164.90 Cr 1,476.80 Cr 718.80 Cr 0.00 Cr 2,289.50 Cr 110.70 Cr 3,024.10 Cr 664.10 Cr
2024-06-30 -987.50 Cr 1,975.00 Cr 987.50 Cr 0.00 Cr 0.00 Cr 987.50 Cr 0.00 Cr 0.00 Cr -1,429.10 Cr
2024-03-31 191.00 Cr 796.50 Cr 987.50 Cr 648.00 Cr 0.00 Cr 1,790.80 Cr 114.40 Cr 2,545.60 Cr 1,116.50 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 117.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 109.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 91.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 87.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 188.60 Cr 188.60 Cr 0.00 Cr 0.00 Cr
2024-03-31 94.80 Cr 153.43 Cr -63.71 Cr -22.53 Cr 68.64 Cr 188.60 Cr 119.96 Cr -1.73 Cr 151.70 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Healthcare Information Services

Company Name Symbol Price Market Cap Volume
Inventurus Knowledge Solutions Ltd. IKS ₹1,578.70 ₹270,862,563,479.00 ₹65,770.00
Sagility India Limited SAGILITY ₹42.39 ₹198,441,519,354.00 ₹24,112,771.00
Indegene Limited INDGN ₹546.45 ₹131,186,065,707.00 ₹394,741.00

Key Executives

Senior Vice President of Corporate Development
Mr. Shouvanik Chatterjee

Gender: male

Year Born:

Vice President of Legal & Group General Counsel
Mr. Karthik Kannappan Saravanan

Gender: male

Year Born:

Chairman & Chief Executive Officer
Mr. Manish Gupta

Gender: male

Year Born:

Senior Vice President of Global Growth Markets, Accounts & Medical Devices
Mr. Marut Setia

Gender: male

Year Born:

Senior Vice President of Global Operations
Mr. Pankaj Kakkar

Gender: male

Year Born:

Chief Financial Officer
Mr. Suhas Prabhu ACA, BCom

Gender: male

Year Born:

Chief Technology Officer
Mr. Tarun Mathur

Gender: male

Year Born:

Company Secretary & Compliance Officer
Ms. Srishti Ramesh Kaushik

Gender: female

Year Born:

Executive Vice President of Global Operations
Mr. Anand Kiran Prafula Chandra Nijegal

Gender: male

Year Born:

Executive Director & Executive Vice President
Dr. Sanjay Suresh Parikh Ph.D.

Gender: Not Specified

Year Born: 1963

FAQs about Indegene Limited

Who is the CEO of the company?

The CEO is Manish Gupta.

What is the current market price of the stock?

The current price is ₹555.85.

What is the 52-week price range?

The range is ₹499-736.3.

What is the market capitalization of the company?

The market capitalization is ₹13,344.27 crores.

What is the dividend yield?

The dividend yield is 0.36%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 32.94.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Indegene Limited (ISIN: INE065X01017) is a leading Medical - Healthcare Information Services in India. With a market capitalization of ₹13,344.27 crores and an average daily volume of 1,183,174 shares, it operates in the Medical - Healthcare Information Services. The company last declared a dividend of ₹2.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack